ESC 365 - Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation

EACVI Premium Access

Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation

Event: EuroCMR 2021

Topic: Diagnostic Methods

Session type: Debate Session

Date: 8 May 2021

Time: 10:30 - 11:20

Session

Become an EACVI member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Sarcoidosis: positron emission tomography (PET) is king.

Speaker: Doctor S. Dorbala (Boston, US)

Sarcoidosis: CMR is king.

Speaker: Doctor A. Patel (Charlottesville, US)

Amyloid: nuclear is king.

Speaker: Doctor A. Gimelli (Pisa, IT)

Amyloid: CMR is king.

Speaker: Professor M. Fontana (London, GB)

Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation - discussion.

4 speakers from this session

Doctor Sharmila Dorbala

Brigham and Women's Hospital, Boston (United States of America)

13 presentations

0 follower

Doctor Amit Patel

University of Virginia, Charlottesville (United States of America)

2 presentations

0 follower

Doctor Alessia Gimelli

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

21 presentations

0 follower

Professor Marianna Fontana

University College London Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

15 presentations

10 followers

This platform is supported by